Atlas Trials

Effect of Acarbose on Postprandial Lipoprotein Levels in Glucose Intolerant Patients

Clinical trial NCT02355509 · COMPLETED

Trial details

NCT number
NCT02355509
Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Glucose IntolerancePostprandial HyperglycemiaCardiovascular Risk Factor
Start date
2010-01-01
Primary completion
2014-07-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.